BackXvivo Perfusion AB (publ) Overview

Xvivo Perfusion AB (publ) Receivables

Track Xvivo Perfusion AB (publ)'s receivables ($200M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$196.02M
↑ 8.36% YoYΔ $15.12M vs prior year quarter

Peer trimmed avg / median

Loading

Xvivo Perfusion AB (publ) Receivables History

Loading

Xvivo Perfusion AB (publ) vs. peers: Receivables Comparison

Loading

Xvivo Perfusion AB (publ) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Xvivo Perfusion AB (publ) (XVIPF) FAQ

Xvivo Perfusion AB (publ) (XVIPF) currently reports a receivables of $200M as of June 2026. That compares with $180M in the prior-year period — up 8.4% year over year. Use the charts on this page to explore Xvivo Perfusion AB (publ)'s receivables history and peer comparisons.

Xvivo Perfusion AB (publ)'s receivables increased from $180M to $200M — a 8.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Xvivo Perfusion AB (publ) reported $200M in receivables as of June 2026. That compares with $180M in the prior-year period — up 8.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Xvivo Perfusion AB (publ), and consider following XVIPF for alerts when major investors trade the stock.